Listing 1 - 10 of 339 | << page >> |
Sort by
|
Choose an application
Choose an application
Choose an application
Choose an application
This volume captures the contents of the talks given at the Workshop on Applications of High Intensity Proton Accelerators held at Fermilab Oct 19-21, 2009. This workshop brought together experts from a variety of disciplines to explore new and profound ways proton accelerators can be used in the future. The workshop explored uses of such a proton source for producing intense muon, kaon and neutrino beams as well as using the intense protons for new forms of nuclear reactors that go by the name Accelerator Driven Sub-critical systems that promise to increase our available nuclear fuel supply b
Choose an application
This comprehensive introduction to high transverse momentum reactions at hadron colliders begins with the Standard Model of high energy physics and a description of the specialized detectors used. It then analyzes the reactions and summarizes the state of the art in hadron collider physics defined by Tevatron results. The experimental program at the detectors being built for the Large Hadron Collider at CERN is also described, with details of the general strategy to find the postulated Higgs particle.
Hadron colliders. --- Proton-antiproton interactions. --- Proton-proton interactions.
Choose an application
Choose an application
Proton pump inhibitors are drugs widely prescribed in gastric acid disorders. These are currently subject to a polemic between experts in the matter. Indeed, over the last ten years, a number of suspicions have accumulated about a potential risk of fracture during the use of proton pump inhibitors. By bringing together the opinions expressed by various federal and European organizations, the results of several meta-analyzes and therapeutic guidance organizations , this thesis goes through the data available so far on this subject and the confrontations between them question asked: what risk of fracture with PPis ? This reflection arrives at a point appointed at a time when Belgium is reviewing the reimbursement criteria for this family of drugs as part of the government’s budgetary efforts. Les inhibiteurs de la pompe à proton sont des médicaments largement prescrits dans les troubles de l’acidité gastrique. Ceux-ci sont actuellement sujets à polémique entre experts en la matière. En effet, depuis une dizaine d’année, un certain nombre de soupçons s’accumulent concernant un risque potentiel de fracture lors de l’usage des inhibiteurs de la pompe à protons. En rassemblant les avis émis par différents organismes de guidance thérapeutique, ce mémoire parcourt les données disponibles à ce jour sur ce sujet et les confrontent entre elles afin de tenter de répondre à la question posée : quel risque de fracture avec les IPPs ? Cette réflexion arrive à point nommé à l’heure où la Belgique est en pleine révision des critères de remboursement de cette famille de médicaments dans le cadre des efforts budgétaires du gouvernement.
Choose an application
Over the past twenty-five years, proton therapy has become more prominent worldwide. It is an important component of clinical radiation therapy for both adult and pediatric clinical care. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology. As such, Proton Therapy - Current Status and Future Directions reviews many aspects of proton care including the application of protons in modern clinical trials. It also reviews problems associated with the migration of proton care worldwide and examines the future direction of proton care. This project was created by colleagues at IntechOpen and was carefully managed by Romina Rovan. It has been a privilege to help coordinate the text and chapters designed to acknowledge the history, footprint, and growing interest of proton care worldwide. Proton management is now embedded in the clinical trials process. In pediatric care, proton delivery is embedded with photons for the management of pediatric malignancies and adult groups have initiated proton-specific clinical trials. A proton registry has been established and outcomes are under evaluation. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology.
Choose an application
Choose an application
Over the past twenty-five years, proton therapy has become more prominent worldwide. It is an important component of clinical radiation therapy for both adult and pediatric clinical care. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology. As such, Proton Therapy - Current Status and Future Directions reviews many aspects of proton care including the application of protons in modern clinical trials. It also reviews problems associated with the migration of proton care worldwide and examines the future direction of proton care. This project was created by colleagues at IntechOpen and was carefully managed by Romina Rovan. It has been a privilege to help coordinate the text and chapters designed to acknowledge the history, footprint, and growing interest of proton care worldwide. Proton management is now embedded in the clinical trials process. In pediatric care, proton delivery is embedded with photons for the management of pediatric malignancies and adult groups have initiated proton-specific clinical trials. A proton registry has been established and outcomes are under evaluation. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology.
Listing 1 - 10 of 339 | << page >> |
Sort by
|